Dyadic International (DYAI) 10-Q2022 Q1 Quarterly report

Filed: 12 May 22, 4:31pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Bad

New words: Abic, add, addendum, American, ARP, Biolgical, capable, cease, committee, constitute, constrained, context, COVID, CTA, disagreement, eligible, entirety, entry, Epygen, figure, free, good, hamster, House, ingredient, Janssen, JDA, Joe, Johnson, joint, jurisdiction, Leprino, letter, LFC, longer, mAb, manuscript, Matthew, mono, mutually, NIIMBL, notice, Novaro, Omicron, Pathology, persistence, Phibro, placebo, prerequisite, proceed, quality, reaching, relevant, renew, Rescue, resolved, SAHPRA, settlement, single, standalone, steering, synthetic, thermophilic, transitioning, White, winding, written

Removed: academic, advancing, affordably, Anticipation, began, brought, cattle, charged, commence, commercialized, commitment, component, coordinated, create, domain, DYAI, efficiently, expanded, expressed, externally, facilitate, fast, Fever, final, forfeited, fulfilled, generation, globally, goal, greater, grow, holding, host, IIBR, improved, incremental, Initiative, insect, Israel, lapse, main, marketability, Medytox, member, modification, modify, multivariant, originated, path, performing, played, positioned, predominantly, range, recombinant, remotely, rent, representing, reserved, restriction, Rift, role, RVFV, safely, SBV, Schmallenberg, serve, sheep, shown, spike, sponsored, stable, surrendered, symbol, tested, top, toxicology, unable, unexercised, Union, uplisting, Valley, variant, variety, Virtual, worked, zapi

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated DYAI transcripts

DYAI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Dyadic International, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark A. Emalfarb, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	May 12, 2022
By:	/s/ Mark A. Emalfarb

Name:	Mark A. Emalfarb
Title:	Chief Executive Officer